T-regulatory cell therapy (BlueRock Therapeutics)

N/A

Report date: 2025/03/20 09:42:23

Base Information

Drug NameT-regulatory cell therapy (BlueRock Therapeutics)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapyCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionRegulatory T-lymphocytes modulators
TargetsUpdating
Therapy Area/IndicationsInflammationAutoimmune DiseasesImmune System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBluerock Therapeutics Lp
China Registration ClassN/A

Develop Information

Active CompaniesBluerock Therapeutics Lp
Inactive CompaniesN/A
Active IndicationsAutoimmune Diseases
Inactive IndicationsInflammationImmune System Diseases

Other Information

ATC CodeN/A
Related LinksN/A